Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships

Advantech (TWSE: 2395), a global leader in industrial IoT and embedded computing solutions, has officially inaugurated its expanded regional office in Singapore. This strategic investment is set to enhance Advantech’s core competencies within the ASEAN region. Located at 7002 Ang Mo Kio Avenue 5, the new office will double the company’s current facility space, enhancingits […]

KM Malta Airlines, the Maltese Islands’ New National Carrier, Implements CellPoint Digital’s Payment Orchestration Solution

The partnership will enable KM Malta Airlines to provide passengers with a seamless payment experience and access to their preferred payment methods. CellPoint Digital, a global pioneer in Payment Orchestration, is proud to announce it has partnered with KM Malta Airlines to support the airline’s payment processes across multiple sales channels, including on its website

GENFIT: Ipsen’s Iqirvo(R) (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that the European Commission has conditionally approved Iqirvo(R)1 (elafibranor) 80mg tablets for the treatment of Primary Biliary Cholangitis (PBC)

Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement

Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement Option entitles Glaukos to exclusive global license agreements on pre-agreed terms including upfront and milestone payments plus royalties Glaukos to fund and conduct NCX 1728 preclinical research activities evaluating it in glaucoma (including neuroprotection) and in other retinal diseases Nicox

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

GENEVA, SWITZERLAND / ACCESSWIRE / September 23, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it will receive a $2 million milestone payment from SWK Funding LLC (SWK) this month, following the U.S.

Mulan Grassland celebrates its first Naadam Festival

WUHAN, China, Sept. 23, 2024 (GLOBE NEWSWIRE) — The Mulan Grassland located in central China’s Wuhan city celebrated its first Naadam Festival on September 21, an event co-hosted by Xilinhot in Inner Mongolia and Huangpi District in Wuhan aiming to deepen cultural exchange and cooperation between the two regions. A Media Snippet accompanying this announcement

QR codes payment Market to Reach $35.07 Billion, Globally, by 2030 at 16.1% CAGR: Allied Market Research

TheQR codes payment market is expected to witness notable growth owing to the massive adoption of QR code payment among merchants and the rise in the usage of smartphones & surge in faster connectivity. https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg Allied Market Research published a report, titled,”QR codes payment Marketby Offering (Solution and Services), Payment Type (Push Payment and Pull

Katch International and Keane MEA Release White Paper on the Evolution and Use of AI in the Hospitality Industry

The White Paper contains invaluable insights from experts on the utilisation and future of AI in the hospitality industry and comprises several interviews with the sector’s top players Leading up to Future Hospitality Summit 2024, Katch International and Keane unveil their informative White Paper on the evolving role of technology in the hospitality industry. Compiled

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine over three years in European patients1 TD is an involuntary movement disorder that develops in around 15%-25% of patients taking antipsychotic medications for conditions such as schizophrenia, bipolar disorder, and major depressive disorder2,3 Data presented at the European

Enterprise Resource Planning (ERP) Market to Reach $117.09 Billion, Globally, by 2030 at 10.0% CAGR: Allied Market Research

The rise in the need for operational efficiency and transparency in business processes and the increase in demand for ERP software from small & medium enterprises boost the growth of the global market. In addition, the surge in adoption of cloud and mobile applications is positively impacting the growth of the market. https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg Allied Market

Scroll to Top